NR3C1 and autoimmune disease: It’s likely that GC treatment may not be able to counteract the dysregulation of B cell subsets, although B cells express the glucocorticoid receptor throughout development and GC therapy has been effective in treating autoimmune diseases in which antibody contributes to pathology, such as rheumatoid arthritis (53).